img

Global Tumor Necrosis Factor Inhibitors Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 282 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tumor Necrosis Factor Inhibitors Sales Market Report 2024

The global Tumor Necrosis Factor Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Necrosis Factor Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Humira
Enbrel
Remicade
Others


Segment by Application


Alzheimer's Diseases
Parkinson's Diseases
Ischemic Stroke
Multiple Sclerosis
Others

The Tumor Necrosis Factor Inhibitors market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Tumor Necrosis Factor Inhibitors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


EPIRUS Biopharmaceuticals
Bionovis
CASI Pharmaceuticals
Janssen Biotech
Momenta Pharmaceuticals
GlaxoSmithKline
HanAll Biopharma
Intas Pharmaceuticals
LEO Pharma
Dexa Medica
LG Life Sciences
MedImmune

Table of Content

1 Tumor Necrosis Factor Inhibitors Market Overview
1.1 Tumor Necrosis Factor Inhibitors Product Scope
1.2 Tumor Necrosis Factor Inhibitors Segment by Type
1.2.1 Global Tumor Necrosis Factor Inhibitors Sales by Type (2016 & 2021 & 2027)
1.2.2 Humira
1.2.3 Enbrel
1.2.4 Remicade
1.2.5 Others
1.3 Tumor Necrosis Factor Inhibitors Segment by Application
1.3.1 Global Tumor Necrosis Factor Inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Alzheimer's Diseases
1.3.3 Parkinson's Diseases
1.3.4 Ischemic Stroke
1.3.5 Multiple Sclerosis
1.3.6 Others
1.4 Tumor Necrosis Factor Inhibitors Market Estimates and Forecasts (2016-2027)
1.4.1 Global Tumor Necrosis Factor Inhibitors Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Tumor Necrosis Factor Inhibitors Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Tumor Necrosis Factor Inhibitors Price Trends (2016-2027)

2 Tumor Necrosis Factor Inhibitors Estimates and Forecasts by Region
2.1 Global Tumor Necrosis Factor Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Tumor Necrosis Factor Inhibitors Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Tumor Necrosis Factor Inhibitors Sales Market Share by Region (2016-2021)
2.2.2 Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Region (2016-2021)
2.3 Global Tumor Necrosis Factor Inhibitors Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Tumor Necrosis Factor Inhibitors Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Tumor Necrosis Factor Inhibitors Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Tumor Necrosis Factor Inhibitors Estimates and Projections (2016-2027)
2.4.2 Europe Tumor Necrosis Factor Inhibitors Estimates and Projections (2016-2027)
2.4.3 China Tumor Necrosis Factor Inhibitors Estimates and Projections (2016-2027)
2.4.4 Japan Tumor Necrosis Factor Inhibitors Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Tumor Necrosis Factor Inhibitors Estimates and Projections (2016-2027)
2.4.6 India Tumor Necrosis Factor Inhibitors Estimates and Projections (2016-2027)

3 Global Tumor Necrosis Factor Inhibitors Competition Landscape by Players
3.1 Global Top Tumor Necrosis Factor Inhibitors Players by Sales (2016-2021)
3.2 Global Top Tumor Necrosis Factor Inhibitors Players by Revenue (2016-2021)
3.3 Global Tumor Necrosis Factor Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Inhibitors as of 2020)
3.4 Global Tumor Necrosis Factor Inhibitors Average Price by Company (2016-2021)
3.5 Manufacturers Tumor Necrosis Factor Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Tumor Necrosis Factor Inhibitors Market Size by Type
4.1 Global Tumor Necrosis Factor Inhibitors Historic Market Review by Type (2016-2021)
4.1.1 Global Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2016-2021)
4.1.2 Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Type (2016-2021)
4.1.3 Global Tumor Necrosis Factor Inhibitors Price by Type (2016-2021)
4.2 Global Tumor Necrosis Factor Inhibitors Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Tumor Necrosis Factor Inhibitors Sales Forecast by Type (2022-2027)
4.2.2 Global Tumor Necrosis Factor Inhibitors Revenue Forecast by Type (2022-2027)
4.2.3 Global Tumor Necrosis Factor Inhibitors Price Forecast by Type (2022-2027)

5 Global Tumor Necrosis Factor Inhibitors Market Size by Application
5.1 Global Tumor Necrosis Factor Inhibitors Historic Market Review by Application (2016-2021)
5.1.1 Global Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2016-2021)
5.1.2 Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Application (2016-2021)
5.1.3 Global Tumor Necrosis Factor Inhibitors Price by Application (2016-2021)
5.2 Global Tumor Necrosis Factor Inhibitors Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Tumor Necrosis Factor Inhibitors Sales Forecast by Application (2022-2027)
5.2.2 Global Tumor Necrosis Factor Inhibitors Revenue Forecast by Application (2022-2027)
5.2.3 Global Tumor Necrosis Factor Inhibitors Price Forecast by Application (2022-2027)

6 North America Tumor Necrosis Factor Inhibitors Market Facts & Figures
6.1 North America Tumor Necrosis Factor Inhibitors Sales by Company
6.1.1 North America Tumor Necrosis Factor Inhibitors Sales by Company (2016-2021)
6.1.2 North America Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021)
6.2 North America Tumor Necrosis Factor Inhibitors Sales Breakdown by Type
6.2.1 North America Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2016-2021)
6.2.2 North America Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2022-2027)
6.3 North America Tumor Necrosis Factor Inhibitors Sales Breakdown by Application
6.3.1 North America Tumor Necrosis Factor Inhibitors Sales Breakdown by Application (2016-2021)
6.3.2 North America Tumor Necrosis Factor Inhibitors Sales Breakdown by Application (2022-2027)

7 Europe Tumor Necrosis Factor Inhibitors Market Facts & Figures
7.1 Europe Tumor Necrosis Factor Inhibitors Sales by Company
7.1.1 Europe Tumor Necrosis Factor Inhibitors Sales by Company (2016-2021)
7.1.2 Europe Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021)
7.2 Europe Tumor Necrosis Factor Inhibitors Sales Breakdown by Type
7.2.1 Europe Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2016-2021)
7.2.2 Europe Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2022-2027)
7.3 Europe Tumor Necrosis Factor Inhibitors Sales Breakdown by Application
7.3.1 Europe 126 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 126 Sales Breakdown by Application (2022-2027)

8 China Tumor Necrosis Factor Inhibitors Market Facts & Figures
8.1 China Tumor Necrosis Factor Inhibitors Sales by Company
8.1.1 China Tumor Necrosis Factor Inhibitors Sales by Company (2016-2021)
8.1.2 China Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021)
8.2 China Tumor Necrosis Factor Inhibitors Sales Breakdown by Type
8.2.1 China Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2016-2021)
8.2.2 China Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2022-2027)
8.3 China Tumor Necrosis Factor Inhibitors Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)

9 Japan Tumor Necrosis Factor Inhibitors Market Facts & Figures
9.1 Japan Tumor Necrosis Factor Inhibitors Sales by Company
9.1.1 Japan Tumor Necrosis Factor Inhibitors Sales by Company (2016-2021)
9.1.2 Japan Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021)
9.2 Japan Tumor Necrosis Factor Inhibitors Sales Breakdown by Type
9.2.1 Japan Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2016-2021)
9.2.2 Japan Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2022-2027)
9.3 Japan Tumor Necrosis Factor Inhibitors Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Tumor Necrosis Factor Inhibitors Market Facts & Figures
10.1 Southeast Asia Tumor Necrosis Factor Inhibitors Sales by Company
10.1.1 Southeast Asia Tumor Necrosis Factor Inhibitors Sales by Company (2016-2021)
10.1.2 Southeast Asia Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021)
10.2 Southeast Asia Tumor Necrosis Factor Inhibitors Sales Breakdown by Type
10.2.1 Southeast Asia Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Tumor Necrosis Factor Inhibitors Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Tumor Necrosis Factor Inhibitors Market Facts & Figures
11.1 India Tumor Necrosis Factor Inhibitors Sales by Company
11.1.1 India Tumor Necrosis Factor Inhibitors Sales by Company (2016-2021)
11.1.2 India Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021)
11.2 India Tumor Necrosis Factor Inhibitors Sales Breakdown by Type
11.2.1 India Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2016-2021)
11.2.2 India Tumor Necrosis Factor Inhibitors Sales Breakdown by Type (2022-2027)
11.3 India Tumor Necrosis Factor Inhibitors Sales Breakdown by Application
11.3.1 India Tumor Necrosis Factor Inhibitors Sales Breakdown by Application (2016-2021)
11.3.2 India Tumor Necrosis Factor Inhibitors Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Tumor Necrosis Factor Inhibitors Business
12.1 EPIRUS Biopharmaceuticals
12.1.1 EPIRUS Biopharmaceuticals Corporation Information
12.1.2 EPIRUS Biopharmaceuticals Business Overview
12.1.3 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.1.4 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Products Offered
12.1.5 EPIRUS Biopharmaceuticals Recent Development
12.2 Bionovis
12.2.1 Bionovis Corporation Information
12.2.2 Bionovis Business Overview
12.2.3 Bionovis Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bionovis Tumor Necrosis Factor Inhibitors Products Offered
12.2.5 Bionovis Recent Development
12.3 CASI Pharmaceuticals
12.3.1 CASI Pharmaceuticals Corporation Information
12.3.2 CASI Pharmaceuticals Business Overview
12.3.3 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Products Offered
12.3.5 CASI Pharmaceuticals Recent Development
12.4 Janssen Biotech
12.4.1 Janssen Biotech Corporation Information
12.4.2 Janssen Biotech Business Overview
12.4.3 Janssen Biotech Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Janssen Biotech Tumor Necrosis Factor Inhibitors Products Offered
12.4.5 Janssen Biotech Recent Development
12.5 Momenta Pharmaceuticals
12.5.1 Momenta Pharmaceuticals Corporation Information
12.5.2 Momenta Pharmaceuticals Business Overview
12.5.3 Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Products Offered
12.5.5 Momenta Pharmaceuticals Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Corporation Information
12.6.2 GlaxoSmithKline Business Overview
12.6.3 GlaxoSmithKline Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.6.4 GlaxoSmithKline Tumor Necrosis Factor Inhibitors Products Offered
12.6.5 GlaxoSmithKline Recent Development
12.7 HanAll Biopharma
12.7.1 HanAll Biopharma Corporation Information
12.7.2 HanAll Biopharma Business Overview
12.7.3 HanAll Biopharma Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.7.4 HanAll Biopharma Tumor Necrosis Factor Inhibitors Products Offered
12.7.5 HanAll Biopharma Recent Development
12.8 Intas Pharmaceuticals
12.8.1 Intas Pharmaceuticals Corporation Information
12.8.2 Intas Pharmaceuticals Business Overview
12.8.3 Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Products Offered
12.8.5 Intas Pharmaceuticals Recent Development
12.9 LEO Pharma
12.9.1 LEO Pharma Corporation Information
12.9.2 LEO Pharma Business Overview
12.9.3 LEO Pharma Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.9.4 LEO Pharma Tumor Necrosis Factor Inhibitors Products Offered
12.9.5 LEO Pharma Recent Development
12.10 Dexa Medica
12.10.1 Dexa Medica Corporation Information
12.10.2 Dexa Medica Business Overview
12.10.3 Dexa Medica Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Dexa Medica Tumor Necrosis Factor Inhibitors Products Offered
12.10.5 Dexa Medica Recent Development
12.11 LG Life Sciences
12.11.1 LG Life Sciences Corporation Information
12.11.2 LG Life Sciences Business Overview
12.11.3 LG Life Sciences Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.11.4 LG Life Sciences Tumor Necrosis Factor Inhibitors Products Offered
12.11.5 LG Life Sciences Recent Development
12.12 MedImmune
12.12.1 MedImmune Corporation Information
12.12.2 MedImmune Business Overview
12.12.3 MedImmune Tumor Necrosis Factor Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.12.4 MedImmune Tumor Necrosis Factor Inhibitors Products Offered
12.12.5 MedImmune Recent Development

13 Tumor Necrosis Factor Inhibitors Manufacturing Cost Analysis
13.1 Tumor Necrosis Factor Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tumor Necrosis Factor Inhibitors
13.4 Tumor Necrosis Factor Inhibitors Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tumor Necrosis Factor Inhibitors Distributors List
14.3 Tumor Necrosis Factor Inhibitors Customers

15 Market Dynamics
15.1 Tumor Necrosis Factor Inhibitors Market Trends
15.2 Tumor Necrosis Factor Inhibitors Drivers
15.3 Tumor Necrosis Factor Inhibitors Market Challenges
15.4 Tumor Necrosis Factor Inhibitors Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tumor Necrosis Factor Inhibitors Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Tumor Necrosis Factor Inhibitors Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Tumor Necrosis Factor Inhibitors Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Region (2016-2021)
Table 5. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Region (2016-2021)
Table 6. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Tumor Necrosis Factor Inhibitors Revenue Share by Region (2016-2021)
Table 8. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Tumor Necrosis Factor Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Tumor Necrosis Factor Inhibitors Revenue Share Forecast by Region (2022-2027)
Table 12. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Tumor Necrosis Factor Inhibitors Sales Share by Company (2016-2021)
Table 14. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Tumor Necrosis Factor Inhibitors Revenue Share by Company (2016-2021)
Table 16. Global Tumor Necrosis Factor Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Inhibitors as of 2020)
Table 17. Global Tumor Necrosis Factor Inhibitors Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Tumor Necrosis Factor Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers Tumor Necrosis Factor Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Type (2016-2021)
Table 22. Global Tumor Necrosis Factor Inhibitors Sales Share by Type (2016-2021)
Table 23. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Tumor Necrosis Factor Inhibitors Sales Share by Type (2022-2027)
Table 26. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Tumor Necrosis Factor Inhibitors Revenue Share by Type (2022-2027)
Table 28. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Application (2016-2021)
Table 30. Global Tumor Necrosis Factor Inhibitors Sales Share by Application (2016-2021)
Table 31. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Application (2022-2027)
Table 34. Global Tumor Necrosis Factor Inhibitors Sales Share by Application (2022-2027)
Table 35. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Tumor Necrosis Factor Inhibitors Revenue Share by Application (2022-2027)
Table 37. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Company (2016-2021)
Table 39. North America Tumor Necrosis Factor Inhibitors Sales Market Share by Company (2016-2021)
Table 40. North America Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Tumor Necrosis Factor Inhibitors Revenue Market Share by Company (2016-2021)
Table 42. North America Tumor Necrosis Factor Inhibitors Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2016-2021)
Table 44. North America Tumor Necrosis Factor Inhibitors Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2022-2027)
Table 46. North America Tumor Necrosis Factor Inhibitors Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2016-2021)
Table 48. North America Tumor Necrosis Factor Inhibitors Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2022-2027)
Table 50. Europe Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Tumor Necrosis Factor Inhibitors Sales Market Share by Company (2016-2021)
Table 52. Europe Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Tumor Necrosis Factor Inhibitors Revenue Market Share by Company (2016-2021)
Table 54. Europe Tumor Necrosis Factor Inhibitors Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2016-2021)
Table 56. Europe Tumor Necrosis Factor Inhibitors Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2022-2027)
Table 58. Europe Tumor Necrosis Factor Inhibitors Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2016-2021)
Table 60. Europe Tumor Necrosis Factor Inhibitors Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2022-2027)
Table 62. China Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Company (2016-2021)
Table 63. China Tumor Necrosis Factor Inhibitors Sales Market Share by Company (2016-2021)
Table 64. China Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Tumor Necrosis Factor Inhibitors Revenue Market Share by Company (2016-2021)
Table 66. China Tumor Necrosis Factor Inhibitors Sales by Type (2016-2021) & (K Pcs)
Table 67. China Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2016-2021)
Table 68. China Tumor Necrosis Factor Inhibitors Sales by Type (2022-2027) & (K Pcs)
Table 69. China Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2022-2027)
Table 70. China Tumor Necrosis Factor Inhibitors Sales by Application (2016-2021) & (K Pcs)
Table 71. China Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2016-2021)
Table 72. China Tumor Necrosis Factor Inhibitors Sales by Application (2022-2027) & (K Pcs)
Table 73. China Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2022-2027)
Table 74. Japan Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Tumor Necrosis Factor Inhibitors Sales Market Share by Company (2016-2021)
Table 76. Japan Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Tumor Necrosis Factor Inhibitors Revenue Market Share by Company (2016-2021)
Table 78. Japan Tumor Necrosis Factor Inhibitors Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2016-2021)
Table 80. Japan Tumor Necrosis Factor Inhibitors Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2022-2027)
Table 82. Japan Tumor Necrosis Factor Inhibitors Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2016-2021)
Table 84. Japan Tumor Necrosis Factor Inhibitors Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Tumor Necrosis Factor Inhibitors Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Tumor Necrosis Factor Inhibitors Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Tumor Necrosis Factor Inhibitors Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Tumor Necrosis Factor Inhibitors Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Tumor Necrosis Factor Inhibitors Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Tumor Necrosis Factor Inhibitors Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2022-2027)
Table 98. India Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Company (2016-2021)
Table 99. India Tumor Necrosis Factor Inhibitors Sales Market Share by Company (2016-2021)
Table 100. India Tumor Necrosis Factor Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Tumor Necrosis Factor Inhibitors Revenue Market Share by Company (2016-2021)
Table 102. India Tumor Necrosis Factor Inhibitors Sales by Type (2016-2021) & (K Pcs)
Table 103. India Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2016-2021)
Table 104. India Tumor Necrosis Factor Inhibitors Sales by Type (2022-2027) & (K Pcs)
Table 105. India Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2022-2027)
Table 106. India Tumor Necrosis Factor Inhibitors Sales by Application (2016-2021) & (K Pcs)
Table 107. India Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2016-2021)
Table 108. India Tumor Necrosis Factor Inhibitors Sales by Application (2022-2027) & (K Pcs)
Table 109. India Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2022-2027)
Table 110. EPIRUS Biopharmaceuticals Corporation Information
Table 111. EPIRUS Biopharmaceuticals Description and Business Overview
Table 112. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Product
Table 114. EPIRUS Biopharmaceuticals Recent Development
Table 115. Bionovis Corporation Information
Table 116. Bionovis Description and Business Overview
Table 117. Bionovis Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Bionovis Tumor Necrosis Factor Inhibitors Product
Table 119. Bionovis Recent Development
Table 120. CASI Pharmaceuticals Corporation Information
Table 121. CASI Pharmaceuticals Description and Business Overview
Table 122. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Product
Table 124. CASI Pharmaceuticals Recent Development
Table 125. Janssen Biotech Corporation Information
Table 126. Janssen Biotech Description and Business Overview
Table 127. Janssen Biotech Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Janssen Biotech Tumor Necrosis Factor Inhibitors Product
Table 129. Janssen Biotech Recent Development
Table 130. Momenta Pharmaceuticals Corporation Information
Table 131. Momenta Pharmaceuticals Description and Business Overview
Table 132. Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Product
Table 134. Momenta Pharmaceuticals Recent Development
Table 135. GlaxoSmithKline Corporation Information
Table 136. GlaxoSmithKline Description and Business Overview
Table 137. GlaxoSmithKline Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. GlaxoSmithKline Tumor Necrosis Factor Inhibitors Product
Table 139. GlaxoSmithKline Recent Development
Table 140. HanAll Biopharma Corporation Information
Table 141. HanAll Biopharma Description and Business Overview
Table 142. HanAll Biopharma Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. HanAll Biopharma Tumor Necrosis Factor Inhibitors Product
Table 144. HanAll Biopharma Recent Development
Table 145. Intas Pharmaceuticals Corporation Information
Table 146. Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Intas Pharmaceuticals Description and Business Overview
Table 148. Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Product
Table 149. Intas Pharmaceuticals Recent Development
Table 150. LEO Pharma Corporation Information
Table 151. LEO Pharma Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. LEO Pharma Description and Business Overview
Table 153. LEO Pharma Tumor Necrosis Factor Inhibitors Product
Table 154. LEO Pharma Recent Development
Table 155. Dexa Medica Corporation Information
Table 156. Dexa Medica Description and Business Overview
Table 157. Dexa Medica Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Dexa Medica Tumor Necrosis Factor Inhibitors Product
Table 159. Dexa Medica Recent Development
Table 160. LG Life Sciences Corporation Information
Table 161. LG Life Sciences Description and Business Overview
Table 162. LG Life Sciences Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. LG Life Sciences Tumor Necrosis Factor Inhibitors Product
Table 164. LG Life Sciences Recent Development
Table 165. MedImmune Corporation Information
Table 166. MedImmune Description and Business Overview
Table 167. MedImmune Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. MedImmune Tumor Necrosis Factor Inhibitors Product
Table 169. MedImmune Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Tumor Necrosis Factor Inhibitors Distributors List
Table 173. Tumor Necrosis Factor Inhibitors Customers List
Table 174. Tumor Necrosis Factor Inhibitors Market Trends
Table 175. Tumor Necrosis Factor Inhibitors Market Drivers
Table 176. Tumor Necrosis Factor Inhibitors Market Challenges
Table 177. Tumor Necrosis Factor Inhibitors Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Necrosis Factor Inhibitors Product Picture
Figure 2. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Type in 2021 & 2027
Figure 3. Humira Product Picture
Figure 4. Enbrel Product Picture
Figure 5. Remicade Product Picture
Figure 6. Others Product Picture
Figure 7. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Application in 2021 & 2027
Figure 8. Alzheimer's Diseases Examples
Figure 9. Parkinson's Diseases Examples
Figure 10. Ischemic Stroke Examples
Figure 11. Multiple Sclerosis Examples
Figure 12. Others Examples
Figure 13. Global Tumor Necrosis Factor Inhibitors Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Tumor Necrosis Factor Inhibitors Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) Growth Rate (2016-2027)
Figure 16. Global Tumor Necrosis Factor Inhibitors Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 17. Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Tumor Necrosis Factor Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Tumor Necrosis Factor Inhibitors Sales (K Pcs) Growth Rate (2016-2027)
Figure 21. Europe Tumor Necrosis Factor Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Tumor Necrosis Factor Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Tumor Necrosis Factor Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Tumor Necrosis Factor Inhibitors Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Tumor Necrosis Factor Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Tumor Necrosis Factor Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Tumor Necrosis Factor Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Tumor Necrosis Factor Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Tumor Necrosis Factor Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Tumor Necrosis Factor Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Tumor Necrosis Factor Inhibitors Players Market Share by Revenue in Tumor Necrosis Factor Inhibitors: 2016 & 2020
Figure 32. Tumor Necrosis Factor Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Tumor Necrosis Factor Inhibitors Revenue Share by Type (2016-2021)
Figure 34. Global Tumor Necrosis Factor Inhibitors Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Tumor Necrosis Factor Inhibitors Revenue Share by Application (2016-2021)
Figure 36. Global Tumor Necrosis Factor Inhibitors Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Tumor Necrosis Factor Inhibitors Sales Market Share by Type in 2020
Figure 38. North America Tumor Necrosis Factor Inhibitors Sales Market Share by Application in 2020
Figure 39. Europe Tumor Necrosis Factor Inhibitors Sales Market Share by Type in 2020
Figure 40. Europe Tumor Necrosis Factor Inhibitors Sales Market Share by Application in 2020
Figure 41. China Tumor Necrosis Factor Inhibitors Sales Market Share by Type in 2020
Figure 42. China Tumor Necrosis Factor Inhibitors Sales Market Share by Application in 2020
Figure 43. Japan Tumor Necrosis Factor Inhibitors Sales Market Share by Type in 2020
Figure 44. Japan Tumor Necrosis Factor Inhibitors Sales Market Share by Application in 2020
Figure 45. Southeast Asia Tumor Necrosis Factor Inhibitors Sales Market Share by Type in 2020
Figure 46. Southeast Asia Tumor Necrosis Factor Inhibitors Sales Market Share by Application in 2020
Figure 47. India Tumor Necrosis Factor Inhibitors Sales Market Share by Type in 2020
Figure 48. India Tumor Necrosis Factor Inhibitors Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Tumor Necrosis Factor Inhibitors
Figure 51. Manufacturing Process Analysis of Tumor Necrosis Factor Inhibitors
Figure 52. Tumor Necrosis Factor Inhibitors Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed